̽»¨Ö±²¥

A simple blood test is being rolled out across the UK as part of a new study to detect early signs of dementia decades before it develops and help identify treatments.

SARS-CoV-2 triggers the production of the antiviral protein IFN-γ, which is associated with fatigue, muscle ache and depression. New research shows that in Long COVID patients, IFN-y production persists until symptoms improve, highlighting a potential biomarker and a target for therapies. 

Dr Diarmuid O’Brien has been appointed as the ̽»¨Ö±²¥ of Cambridge’s new Pro-Vice-Chancellor for Innovation. He is currently Chief Executive of , the ̽»¨Ö±²¥â€™s commercialisation arm which supports academics, researchers, staff and students in achieving knowledge transfer and research impact.

̽»¨Ö±²¥facility, based at the Milner Therapeutics Institute, will support the discovery of new medicines and diagnostics for chronic diseases by applying advanced biological and technological tools, including CRISPR gene editing.

 An ambitious new strategy to nurture and grow its innovation ecosystem has been unveiled at Cambridge summit.

A new fleet of nine electric buses will operate on an extended Universal bus route from October, after the ̽»¨Ö±²¥ of Cambridge and Whippet buses announced a new 8-year contract for the popular Cambridge service.

Cambridge scientists have shown that the hypothalamus, a key region of the brain involved in controlling appetite, is different in the brains of people who are overweight and people with obesity when compared to people who are a healthy weight.

An international team of researchers has found a genetic variant that may explain why some people of African ancestry have naturally lower viral loads of HIV, reducing their risk of transmitting the virus and slowing progress of their own illness.

For the first time, the has observed the chemical signature of carbon-rich dust grains in the early universe.

100 organisations, including AstraZeneca, Microsoft and Arm, have signed up to a new charter to boost the Cambridge innovation ecosystem and help it address global challenges, announced Innovate Cambridge today (8 December 2022).